nicotinamide
PFK201707
Phase 2 small_molecule active
Quick answer
nicotinamide for Cutaneous Lupus Erythematosus is a Phase 2 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Cutaneous Lupus Erythematosus
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active